Maven Clinic: Kate Ryder and the Future of Women's Health

In 2014, Kate Ryder was a venture capitalist at Maverick Capital, watching the digital health space from the outside. She kept noticing the same gap: women's health was chronically underserved, underfunded, and poorly understood by the healthcare system. Fertility, pregnancy, postpartum care, menopause, mental health tied to reproductive cycles. These were not niche concerns. They were the lived experience of half the population, and the existing system was largely failing them.

She left venture capital and founded Maven Clinic in 2014 with a straightforward premise: build a virtual clinic that actually specializes in women's and family health, staffed by practitioners who understand it, and make it accessible on demand. The idea was not complicated. The execution was.

A decade later, Maven is the largest virtual clinic of its kind in the world. It has raised more than $300 million in funding, reached a valuation of over $1.7 billion, and built a network of more than 30,000 providers across 35 specialties. Its employer and health plan clients include some of the largest companies in the United States. And it has done something arguably more significant than any of those numbers: it has forced a serious conversation about how the American healthcare system values, or fails to value, women's health.

The Gap That Built a Billion-Dollar Company

The statistics that motivated Ryder were not subtle. The United States has the highest maternal mortality rate of any high-income country. Postpartum depression affects roughly one in five new mothers and is dramatically undertreated. Women are more likely than men to have their pain dismissed by physicians, more likely to be misdiagnosed for conditions including heart disease and autoimmune disorders, and more likely to leave a medical appointment without answers.

At the same time, the life events most specific to women, pregnancy, fertility treatment, miscarriage, postpartum recovery, perimenopause, are among the most medically complex and emotionally demanding experiences a person can go through. The existing system was not designed to support them well. Appointments were short, specialists were hard to access, and the coordination between different types of care was often nonexistent.

Maven's answer was to build a platform that could provide continuous, coordinated care across the full arc of women's and family health. Not just a telehealth app for quick consultations, but a genuine clinical ecosystem where an OB-GYN, a mental health provider, a lactation consultant, a nutritionist, and a career coach could all be part of the same care experience.

"The existing system was not designed to support women well. Maven's answer was to build a platform that could provide continuous, coordinated care across the full arc of women's and family health."

The Employer Channel

One of Ryder's most consequential strategic decisions was to go to market primarily through employers and health plans rather than directly to consumers. The logic was both practical and systemic. Employers bear enormous costs related to women's health outcomes, from NICU stays for premature births to turnover driven by inadequate parental leave support to lost productivity from untreated postpartum depression. If Maven could demonstrate that better care reduced those costs, it could build a sustainable business while improving outcomes at scale.

The pitch worked. Maven's client roster grew to include companies like Microsoft, Snap, Condé Nast, and dozens of others that saw women's health benefits as both a talent retention tool and a genuine cost management strategy. A 2020 study found that Maven members had a 27 percent reduction in preterm births and a 24 percent reduction in NICU admissions compared to non-members. Those are not marginal improvements. They represent significant reductions in human suffering and in healthcare costs.

The employer channel also gave Maven something that direct-to-consumer health companies often struggle to achieve: a path to scale that did not require convincing millions of individual consumers to pay out of pocket for a new kind of healthcare. By embedding Maven into existing benefits packages, Ryder could reach employees who might never have sought out the service on their own.

Changing What Insurers Cover

Perhaps the most lasting impact of Maven's growth has been on how health insurers think about women's health coverage. For decades, the actuarial logic of insurance treated many aspects of women's health as either elective or insufficiently evidence-based to justify coverage. Fertility treatments, lactation support, mental health care tied to reproductive events, these were often excluded or severely limited.

Maven's outcomes data has been a direct challenge to that logic. When you can show that covering comprehensive maternity support reduces NICU costs by millions of dollars, the conversation about what counts as medically necessary changes. Several major health plans have expanded their coverage of services that Maven provides, not out of altruism but because the data made a compelling economic case.

Ryder has been explicit about this goal. She has described Maven not just as a healthcare company but as a vehicle for changing the structural inequities in how women's health is funded and delivered. That framing has made the company a focal point in a broader conversation about gender equity in medicine, a conversation that has gained significant momentum in the years since Maven was founded.

The Femtech Moment

Maven did not emerge in isolation. It is part of a broader wave of femtech companies, a term that has become shorthand for technology-driven businesses focused on women's health, that has attracted significant investor attention over the past decade. Companies like Progyny, Hims & Hers, Kindbody, and Tia have collectively raised billions of dollars and built businesses around the same fundamental insight that Ryder identified: women's health is a massive, underserved market.

What distinguishes Maven within that landscape is the breadth of its clinical scope and the depth of its employer relationships. Many femtech companies have focused on specific moments, fertility, pregnancy, menopause, and built strong products for those windows. Maven has tried to build something more continuous, a platform that follows a woman through her entire reproductive life and into family health more broadly.

That ambition has required significant capital and significant patience. Building a clinical network of 30,000 providers, maintaining quality standards across dozens of specialties, and integrating with the complex infrastructure of employer benefits and health plan administration is not a simple product problem. It is an operational challenge of considerable scale.

What Ryder Built

Kate Ryder is not a physician. She came to healthcare from finance and journalism, with a perspective shaped more by systems thinking than clinical training. That background may be part of what allowed her to see the structural problem clearly: this was not primarily a medical knowledge gap but a delivery and access gap, and those are problems that technology and business model innovation can address.

The company she built reflects that perspective. Maven is not trying to replace the existing healthcare system. It is trying to fill the spaces that system consistently leaves empty, the gaps between appointments, the coordination failures between specialists, the moments when a new mother at 2 a.m. needs to talk to a lactation consultant and has no way to reach one.

In doing so, Ryder has built something that is simultaneously a successful business and a genuine argument about how healthcare should work. The argument is simple: when you actually invest in women's health, when you staff it properly, coordinate it thoughtfully, and make it accessible, outcomes improve and costs go down. The data backs it up. The question now is how much of the broader healthcare system is willing to listen.